DECIPHERA PHARMACEUT

DCPH
Delayed Quote. Delayed  - 12/03 04:00:00 pm
8USD -2.79%

Turn to zoom
Prev.8.0000
Open8.1700
High8.3000
Low7.7800
Volume1 102 560
Latest news
1d ago
3d ago
3d ago
4d ago
Chart DECIPHERA PHARMACEUTICALS, INC.
Technical analysis trends
Short TermMid-TermLong Term
TrendBearishBearishBearish
Resistance16,516,520,7
Spread/Res.-52%-52%-61%
Spread/Supp.3,9%3,9%94%
Support7,707,704,13
Financials
Sales 2021 95,3 M - -
Net income 2021 -295 M - -
Net cash 2021 73,0 M - -
P/E ratio 2021 -1,57x
Yield 2021 -
Capitalization 468 M 468 M -
EV / Sales 2021 4,14x
EV / Sales 2022 2,69x
Nbr of Employees 350
Free-Float 71,0%
Company
Deciphera Pharmaceuticals, Inc. is a biopharmaceutical company focused on discovering, developing, and delivering medicines to patients for the treatment of cancer. The Company developed a switch-control kinase inhibitor platform in kinase biology to execute its strategy to develop a broad...

>> Read more
Sector :
Bio Therapeutic Drugs
Calendar :
2022-03-16 Earnings Release
Trading Rating :
Investor Rating :

Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 11
Last Close Price 8,00 $
Average target price 13,00 $
Spread / Average Target 62,5%